Latest Regulation News

Page 107 of 109
Bulletin Resources continues its appeal against the refusal of a Native Vegetation Clearing Permit critical to advancing drilling at its Ravensthorpe Lithium Project, while maintaining a strong cash position and reviewing strategic opportunities.
Maxwell Dee
Maxwell Dee
28 Jan 2025
Lakes Blue Energy has responded to ASX concerns over delayed disclosure of director interest changes, attributing the issue to administrative oversights and reaffirming its commitment to compliance.
Maxwell Dee
Maxwell Dee
28 Jan 2025
5G Networks Limited has increased its on-market takeover offer for AuCyber Limited from 11 cents to 13.5 cents per share, marking its final bid ahead of the January 30 deadline.
Victor Sage
Victor Sage
28 Jan 2025
OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.
Victor Sage
Victor Sage
28 Jan 2025
OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.
Maxwell Dee
Maxwell Dee
28 Jan 2025
EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.
Ada Torres
Ada Torres
28 Jan 2025
Viridis Mining & Minerals has cleared major environmental and regulatory hurdles for its Colossus Rare Earth Project, securing critical local government endorsements and submitting comprehensive impact assessments that pave the way for construction in 2026.
Victor Sage
Victor Sage
28 Jan 2025
Kingfisher Mining has confirmed two new rare earth element lodes and reported exceptional copper assays, bolstering its position in the Gascoyne region amid ongoing strategic diversification.
Maxwell Dee
Maxwell Dee
28 Jan 2025
Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.
Victor Sage
Victor Sage
28 Jan 2025
Flagship Investments Limited has released its quarterly report confirming a stable loan-to-value ratio of 19.77% and full compliance with regulatory requirements for the period ending December 2024.
Claire Turing
Claire Turing
24 Jan 2025
ECP Emerging Growth Limited has reported steady financial health and full compliance with its convertible notes obligations for the quarter ended December 2024, maintaining a conservative loan-to-value ratio and an unchanged conversion price.
Claire Turing
Claire Turing
24 Jan 2025
Multistack International Limited reported steady sales of water chillers in Q4 2024 while progressing toward a settlement in its arbitration with Danfoss. The company maintains a solid cash position supported by related-party loans as it continues to promote its ORC technology aligned with global carbon reduction goals.
Victor Sage
Victor Sage
24 Jan 2025